VIR - 2 Stocks That Could Turn $100 Into $1000 by 2028
Turning a $100 investment into $1,000 in five years isn't easy. Doing so requires a substantial compound annual growth rate (CAGR) exceeding 58%. You're not likely to see such a rate among value stocks, which for all their consistency rarely grow at that pace.
Two companies where I see that kind of progress over the next five years are Vir Biotechnology (NASDAQ: VIR) and Albemarle (NYSE: ALB) .
While risk goes hand-in-hand with growth stocks , both companies have strong tailwinds. In Vir's case, it's the potential of its hepatitis drugs. For Albemarle, the need for lithium in electric vehicles should supercharge its earnings.
For further details see:
2 Stocks That Could Turn $100 Into $1,000 by 2028